Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma

PURPOSE OF REVIEW: This paper aims to summarize the data of recently completed and key ongoing clinical trials of systemic agents for advanced hepatocellular carcinoma (aHCC). In particular, the review focuses on ongoing checkpoint inhibitor combination trials and promising studies combining tyrosin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Curr Hepatol Rep
Main Authors: Aitcheson, Gabriella, Pillai, Anjana, Dahman, Bassam, John, Binu V
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2021
Teme:
Hepatic Cancer (N Parikh, Section Editor)
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7848044/
https://ncbi.nlm.nih.gov/pubmed/33552839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11901-021-00560-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki